Related Experiment Videos
Second-line for small cell lung cancer: how-to-do-it?
Lung Cancer (Amsterdam, Netherlands)
|April 15, 2005
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Ninety-day mortality following curative intent radiotherapy for stage I-III lung cancer in the Netherlands.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2024
Familial multiple discoid fibromas is linked to a locus on chromosome 5 including the FNIP1 gene.
Journal of human genetics·2023
Real-World Approach for Molecular Analysis of Acquired EGFR Tyrosine Kinase Inhibitor Resistance Mechanisms in NSCLC.
JTO clinical and research reports·2021
Outcomes of robotic vs video-assisted thoracoscopic segmentectomy in early-stage NSCLC: A meta-analysis of propensity-matched studies.
Lung cancer (Amsterdam, Netherlands)·2026
Feasibility assessment of implementing lung cancer screening among current and former heavy smokers: a national pilot program in Israel (2021-2024).
Lung cancer (Amsterdam, Netherlands)·2026
Germline testing in lung cancer: evidence of enrichment without a standardized selection strategy - a systematic review.
Lung cancer (Amsterdam, Netherlands)·2026
Adjuvant chemotherapy intensity and prognosis in completely resected high-grade neuroendocrine lung carcinoma: a post hoc analysis of JCOG1205/1206.
Lung cancer (Amsterdam, Netherlands)·2026
Nanoparticle-based drug delivery for precision lung cancer therapy: Tumor microenvironment modulation and theranostic applications.
Lung cancer (Amsterdam, Netherlands)·2026
ULK1, a novel therapeutic target to delay drug tolerance to EGFR-TKIs in an EGFR-mutant non-small cell lung cancer model.
Lung cancer (Amsterdam, Netherlands)·2026
Outcomes of nucleos(t)ide analogue discontinuation following finite xalnesiran-based therapies in chronic hepatitis B.
JHEP reports : innovation in hepatology·2026
Syringeable hyaluronic acid-based hydrogel co-loaded with Cisplatin and MSA-2 for enhanced ovarian cancer chemoimmunotherapy.
Biomedical materials (Bristol, England)·2026
Caffeine in the Context of Sorafenib Chemotherapy: Insights From Experimental Hepatocarcinogenesis.
Journal of biochemical and molecular toxicology·2026